drugset / Trial / NCT00427154
Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA). This trial will compare the changes in HbA1c after 26 weeks of inhaled insulin or rosiglitazone treatment, both in combination with metformin and glimepiride.
Timeline
- Start
- 2007-01-10
- Primary completion
- 2008-03-11
- Completion
- 2008-03-11
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosiglitazone | Small molecule | 4 mg | Oral |
| Comparator | human insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | Glimepiride | Small molecule | 8 mg | Oral |
| Comparator | Metformin | Small molecule | 2000 mg | Oral |